Table 2.
Groups | Litters (No.) |
Implantations
(No.) |
Resorbed fetuses (%) | Live fetuses (%) | Fetal length (mm) | Fetal weight (g) |
---|---|---|---|---|---|---|
Control | 7 | 49 | 2(4.09)a | 47(95.91)a | 37.3 ± 0.31a | 4.73 ± 0.07a |
Cyclophosphamide (CP; 15 mg kg -1 ) | 6 | 41 | 23(56.09)b | 18(43.90)c | 27.83 ± 1.34 c | 1.96 ± 0.20c |
Quercetin (mg kg -1 ) | 6 | 38 | 3(7.89)a | 35(92.11)a | 34.64 ± 0.68b | 3.12 ± 0.10b |
Quercetin (200 mg kg -1 ) | 6 | 42 | 3(7.14)a | 39(92.86)a | 29.13 ± 0.69b | 3.29 ± 0.08c |
CP + quercetin (75 mg kg -1 ) | 5 | 36 | 11(30.56)c | 25(69.44)b | 32.94 ± 0.53b | 2.46 ± 0.13e |
CP + quercetin (200 mg kg -1 ) | 5 | 39 | 8(20.52)c | 31(79.48)b | 33.85 ± 0.45c | 2.24 ± 0.10ce |
Different letters indicate significant differences each parameter between groups (p ≤ 0.05).